JP2010513222A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513222A5
JP2010513222A5 JP2009523811A JP2009523811A JP2010513222A5 JP 2010513222 A5 JP2010513222 A5 JP 2010513222A5 JP 2009523811 A JP2009523811 A JP 2009523811A JP 2009523811 A JP2009523811 A JP 2009523811A JP 2010513222 A5 JP2010513222 A5 JP 2010513222A5
Authority
JP
Japan
Prior art keywords
difluorophenyl
triazol
chloro
propyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513222A (ja
Filing date
Publication date
Priority claimed from EP06380225A external-priority patent/EP1887004A1/en
Priority claimed from EP07380186A external-priority patent/EP2009009A1/en
Application filed filed Critical
Priority claimed from PCT/US2007/017476 external-priority patent/WO2008021049A2/en
Publication of JP2010513222A publication Critical patent/JP2010513222A/ja
Publication of JP2010513222A5 publication Critical patent/JP2010513222A5/ja
Pending legal-status Critical Current

Links

Images

JP2009523811A 2006-08-07 2007-08-06 結晶抗真菌化合物 Pending JP2010513222A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83586306P 2006-08-07 2006-08-07
EP06380225A EP1887004A1 (en) 2006-08-07 2006-08-07 Crystalline forms of (1R,2R)-7-Chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one
US92940807P 2007-06-26 2007-06-26
EP07380186A EP2009009A1 (en) 2007-06-26 2007-06-26 Crystalline antifungal compounds
PCT/US2007/017476 WO2008021049A2 (en) 2006-08-07 2007-08-06 Crystalline antifungal compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013154163A Division JP2014012673A (ja) 2006-08-07 2013-07-25 結晶抗真菌化合物

Publications (2)

Publication Number Publication Date
JP2010513222A JP2010513222A (ja) 2010-04-30
JP2010513222A5 true JP2010513222A5 (enExample) 2010-09-24

Family

ID=39082545

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009523811A Pending JP2010513222A (ja) 2006-08-07 2007-08-06 結晶抗真菌化合物
JP2013154163A Pending JP2014012673A (ja) 2006-08-07 2013-07-25 結晶抗真菌化合物
JP2015137404A Pending JP2015193642A (ja) 2006-08-07 2015-07-09 結晶抗真菌化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013154163A Pending JP2014012673A (ja) 2006-08-07 2013-07-25 結晶抗真菌化合物
JP2015137404A Pending JP2015193642A (ja) 2006-08-07 2015-07-09 結晶抗真菌化合物

Country Status (17)

Country Link
US (2) US7879867B2 (enExample)
EP (2) EP2650291B1 (enExample)
JP (3) JP2010513222A (enExample)
KR (1) KR20090053903A (enExample)
CN (1) CN103232442B (enExample)
AR (1) AR062232A1 (enExample)
AU (1) AU2007284851B2 (enExample)
BR (1) BRPI0716026A2 (enExample)
CA (1) CA2658843A1 (enExample)
DK (1) DK2650291T3 (enExample)
ES (1) ES2652670T3 (enExample)
IL (2) IL196722A (enExample)
IN (1) IN2014MN01560A (enExample)
MX (1) MX2009001208A (enExample)
RU (1) RU2500679C2 (enExample)
TW (1) TWI426073B (enExample)
WO (1) WO2008021049A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006018853A2 (en) 2004-08-19 2006-02-23 Hetero Drugs Limited Novel polymorphs of efavirenz
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
KR20120079054A (ko) * 2009-07-10 2012-07-11 에볼바 아게 디인 조성물
CN105503870A (zh) * 2009-08-14 2016-04-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
US9435692B2 (en) 2014-02-05 2016-09-06 Lam Research Corporation Calculating power input to an array of thermal control elements to achieve a two-dimensional temperature output
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
GB201410407D0 (en) * 2014-06-11 2014-07-23 Univ Dundee And Syngene Internat Ltd Plc And Consejo Superior De Investigaciones Cientificas And Med Treatment of chagas disease
EA025187B1 (ru) * 2015-04-17 2016-11-30 Тагир Аббасели оглы Сулейманов Производное дитиокарбамата 2-((4-(4-метилпиперазин-1-ил)фенил)амино)-2-оксоетил4-этилпиперазин-1-карбодитиоат, обладающее антифунгальной активностью
JP2025505889A (ja) 2021-12-22 2025-03-03 パラウ ファルマ，エス．エル．ユー． 多粒子アルバコナゾール組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293500A1 (en) 1987-06-01 1988-12-07 American Cyanamid Company 3-heteroalkyl-2,4.quinzaoline-diones
GB8819308D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
TW218017B (enExample) 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
TW297813B (enExample) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
DK0783501T3 (da) * 1995-08-02 2001-01-29 Uriach & Cia Sa J Pyrimidonderivater med anti-fungal aktivitet
AU6119798A (en) 1997-03-05 1998-09-22 Takeda Chemical Industries Ltd. Crystalline form of a bis 1,2,4-triazole compound
ES2159488B1 (es) * 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.

Similar Documents

Publication Publication Date Title
JP2010513222A5 (enExample)
RU2009104959A (ru) Кристаллические противогрибковые соединения
EP2007758B1 (en) A novel crystalline form of lamivudine
JP2015522644A5 (enExample)
TWI333419B (en) Crystalline sodium salt, process for the manufacture thereof and use thereof for the preparation of a medicament
JP2018531280A5 (enExample)
ES2198915T3 (es) Azoles solubles en agua como antifungicos de amplio espectro.
JP2010514725A5 (enExample)
WO2009156837A3 (en) Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt
JP2016537326A5 (enExample)
WO2014167428A2 (en) Amorphous 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-n-methylbenzamide
CN103755723B (zh) 一种利福平i晶型的制备方法
WO2009037538A2 (en) Process for the preparation of lamivudine form i
CA2993134A1 (en) Crystalline forms of bilastine and preparation methods thereof
JPWO2020069024A5 (enExample)
CN104892602B (zh) 一种1,2,4-三唑[4,3-a]吡啶环的腙衍生物及其制备与应用
CN103965185B (zh) 含有噻唑基和酯基的1,5-苯并二氮杂卓化合物及其应用
CN108440518A (zh) 3-(2-氨基噻唑)-7-取代哌嗪类喹诺酮化合物及其制备方法和应用
JP2019500385A5 (enExample)
CA3232656A1 (en) Crystal form of imidazolinone derivative
JP4610744B2 (ja) 抗菌・抗カビ性エーテル類
CN106866533A (zh) 吡唑醚菌酯晶型及制备方法
CN113444053A (zh) 一种丙硫菌唑晶型及其制备方法与用途
CN101516858B (zh) 晶体抗真菌化合物
WO2014189308A1 (ko) 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법